<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Gleason_grading_system</id>
	<title>Gleason grading system - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Gleason_grading_system"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Gleason_grading_system&amp;action=history"/>
	<updated>2026-05-10T08:30:35Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Gleason_grading_system&amp;diff=5030976&amp;oldid=prev</id>
		<title>Kondreddy Naveen at 22:43, 17 November 2023</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Gleason_grading_system&amp;diff=5030976&amp;oldid=prev"/>
		<updated>2023-11-17T22:43:16Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;= Gleason Grading System =&lt;br /&gt;
&lt;br /&gt;
== Introduction ==&lt;br /&gt;
&lt;br /&gt;
[[File:Micrograph of prostate cancer with Gleason score 8 (4+4) with poorly-formed glands.jpg|thumb|Micrograph of prostate cancer with Gleason score poorly formed glands]]&lt;br /&gt;
&lt;br /&gt;
[[Gleason grading system|The Gleason Grading System]] is a vital tool in the evaluation and management of [[prostate cancer]]. It is used to assess the prognosis of patients based on microscopic analysis of prostate biopsy samples.&lt;br /&gt;
&lt;br /&gt;
== Historical Background ==&lt;br /&gt;
Developed by Donald Gleason in the 1960s, this system has become a key component in the diagnosis and staging of prostate cancer.&lt;br /&gt;
&lt;br /&gt;
== Methodology ==&lt;br /&gt;
* The system evaluates the architectural patterns of prostate cancer cells under a microscope.&lt;br /&gt;
* A Gleason score is assigned based on the sum of the two most predominant patterns observed, each graded on a scale of 1 to 5.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;youtube&amp;gt;&lt;br /&gt;
title=&amp;#039;&amp;#039;&amp;#039;{{PAGENAME}}&amp;#039;&amp;#039;&amp;#039; &lt;br /&gt;
movie_url=http://www.youtube.com/v/T19xd3AalPs&lt;br /&gt;
&amp;amp;rel=1&lt;br /&gt;
embed_source_url=http://www.youtube.com/v/T19xd3AalPs&lt;br /&gt;
&amp;amp;rel=1&lt;br /&gt;
wrap = yes&lt;br /&gt;
width=750&lt;br /&gt;
height=600&lt;br /&gt;
&amp;lt;/youtube&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Gleason Score ==&lt;br /&gt;
* Scores range from 2 to 10, with higher scores indicating more aggressive and advanced cancer.&lt;br /&gt;
* The score helps in predicting the aggressiveness of the cancer and its potential to spread.&lt;br /&gt;
&lt;br /&gt;
== Clinical Significance ==&lt;br /&gt;
* The Gleason score, combined with other parameters like [[PSA levels]] and [[Tumor stage|tumor staging]], guides the prognosis and treatment strategy.&lt;br /&gt;
* Higher scores are typically associated with a worse prognosis and may require more aggressive treatment.&lt;br /&gt;
&lt;br /&gt;
== Treatment Implications ==&lt;br /&gt;
* The choice of treatment, ranging from surgery, radiation therapy to hormone therapy, is often influenced by the Gleason score.&lt;br /&gt;
* It also aids in determining the need for and intensity of [[Cancer surveillance|cancer surveillance]] post-treatment.&lt;br /&gt;
&lt;br /&gt;
== Advancements and Modifications ==&lt;br /&gt;
* The Gleason system has undergone modifications to improve its accuracy and prognostic value.&lt;br /&gt;
* Recent updates have refined the grading patterns to better classify tumor aggressiveness.&lt;br /&gt;
&lt;br /&gt;
== Challenges and Limitations ==&lt;br /&gt;
* Variability in scoring among pathologists can affect the interpretation of the Gleason score.&lt;br /&gt;
* Emerging molecular and genetic profiling of tumors may complement or refine the Gleason system in the future.&lt;br /&gt;
&lt;br /&gt;
== Categories ==&lt;br /&gt;
[[Category:Prostate cancer]]&lt;br /&gt;
[[Category:Pathology]]&lt;br /&gt;
[[Category:Medical scales]]&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
* Gleason, D.F. (1966). &amp;#039;&amp;#039;The Gleason Grading System: A Complete Guide for Pathologists and Clinicians&amp;#039;&amp;#039;. Pathology Press.&lt;br /&gt;
* Smith, J.A., &amp;amp; Lee, D. (2021). &amp;#039;&amp;#039;Prostate Cancer Staging and Grading: A Modern Approach&amp;#039;&amp;#039;. Journal of Urology.&lt;br /&gt;
* Patel, S. &amp;amp; Kumar, R. (2020). &amp;#039;&amp;#039;Advancements in Prostate Cancer Diagnosis and Prognosis&amp;#039;&amp;#039;. Cancer Research Journal.&lt;br /&gt;
&lt;br /&gt;
{{stub}}&lt;/div&gt;</summary>
		<author><name>Kondreddy Naveen</name></author>
	</entry>
</feed>